MEDF Stock Overview
Medfield Diagnostics AB (publ) engages in the development and sale of medical devices based on microwave technology.
Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 4/6 |
Dividends | 0/6 |
Medfield Diagnostics AB (publ) Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | kr0.30 |
52 Week High | kr3.68 |
52 Week Low | kr0.21 |
Beta | 1.08 |
1 Month Change | 0% |
3 Month Change | -29.88% |
1 Year Change | -91.58% |
3 Year Change | -93.61% |
5 Year Change | -95.73% |
Change since IPO | -91.95% |
Recent News & Updates
Shareholder Returns
MEDF | SE Medical Equipment | SE Market | |
---|---|---|---|
7D | 0% | 4.3% | 1.9% |
1Y | -91.6% | -3.4% | 17.1% |
Return vs Industry: MEDF underperformed the Swedish Medical Equipment industry which returned -3.9% over the past year.
Return vs Market: MEDF underperformed the Swedish Market which returned 19% over the past year.
Price Volatility
MEDF volatility | |
---|---|
MEDF Average Weekly Movement | n/a |
Medical Equipment Industry Average Movement | 8.0% |
Market Average Movement | 6.1% |
10% most volatile stocks in SE Market | 12.9% |
10% least volatile stocks in SE Market | 3.4% |
Stable Share Price: MEDF's share price has been volatile over the past 3 months.
Volatility Over Time: Insufficient data to determine MEDF's volatility change over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2005 | 8 | Bjorn Larsson | https://www.medfielddiagnostics.com |
Medfield Diagnostics AB (publ) engages in the development and sale of medical devices based on microwave technology. It offers Strokefinder MD100, a device for decision-support to assist in clinical evaluation and triage of suspected intracranial injuries in the acute situation. The company was incorporated in 2005 and is based in Gothenburg, Sweden.
Medfield Diagnostics AB (publ) Fundamentals Summary
MEDF fundamental statistics | |
---|---|
Market cap | kr23.64m |
Earnings (TTM) | -kr15.02m |
Revenue (TTM) | kr7.19m |
3.3x
P/S Ratio-1.6x
P/E RatioIs MEDF overvalued?
See Fair Value and valuation analysisEarnings & Revenue
MEDF income statement (TTM) | |
---|---|
Revenue | kr7.19m |
Cost of Revenue | kr1.73m |
Gross Profit | kr5.46m |
Other Expenses | kr20.48m |
Earnings | -kr15.02m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
Apr 19, 2024
Earnings per share (EPS) | -0.19 |
Gross Margin | 75.96% |
Net Profit Margin | -208.92% |
Debt/Equity Ratio | 0% |
How did MEDF perform over the long term?
See historical performance and comparison